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Abstract. 
 
The 
 
MPS1
 
 gene from 
 
Saccharomyces cerevi-
siae
 
 encodes an essential protein kinase required for 
spindle pole body (SPB) duplication and for the mitotic 
spindle assembly checkpoint. Cells with the 
 
mps1-1
 
 mu-
tation fail early in SPB duplication and proceed 
through monopolar mitosis with lethal consequences. 
We identified 
 
CDC37
 
 as a multicopy suppressor of 
 
mps1-1
 
 temperature-sensitive growth. Suppression is 
allele specific, and synthetic lethal interactions occur 
between 
 
mps1
 
 and 
 
cdc37
 
 alleles. We examined the 
 
cdc37-1
 
 phenotype for defects related to the SPB cycle. 
The 
 
cdc37-1
 
 temperature-sensitive allele causes unbud-
ded, G1 arrest at Start (Reed, S.I. 1980. 
 
Genetics.
 
 95:
561–577). Reciprocal shifts demonstrate that 
 
cdc37-1
 
 
arrest is interdependent with 
 
a
 
-factor arrest but is not a 
normal Start arrest. Although the cells are responsive 
to 
 
a
 
-factor at the arrest, SPB duplication is uncoupled 
from other aspects of G1 progression and proceeds past 
the satellite-bearing SPB stage normally seen at Start. 
Electron microscopy reveals side-by-side SPBs at 
 
cdc37-1
 
 arrest. The outer plaque of one SPB is missing 
or reduced, while the other is normal. Using the 
 
mps2-1
 
 
mutation to distinguish between the SPBs, we find that 
the outer plaque defect is specific to the new SPB. This 
phenotype may arise in part from reduced Mps1p func-
tion: although Mps1p protein levels are unaffected by 
the 
 
cdc37-1
 
 mutation, kinase activity is markedly re-
duced. These data demonstrate a requirement for 
 
CDC37
 
 in SPB duplication and suggest a role for this 
gene in G1 control. 
 
CDC37
 
 may provide a chaperone 
function that promotes the activity of protein kinases.
 
T
 
he
 
 centrosome serves as the microtubule-organiz-
ing center of the eukaryotic cell and must be pre-
cisely duplicated once during each cell cycle to pro-
vide the poles of the mitotic spindle (Kellogg et al., 1994).
In the yeast 
 
Saccharomyces cerevisiae
 
, centrosomal func-
tions are provided by the spindle pole body (SPB)
 
1
 
 (for re-
views see Kilmartin, 1994; Snyder, 1994). This trilaminar
disk is embedded in the nuclear envelope throughout the
cell cycle and nucleates microtubule arrays in the nucleus
and cytoplasm. Electron microscopy reveals a darkly stain-
ing disk in the plane of the nuclear envelope, called the
central plaque, which is flanked by less darkly staining
disks on its nuclear and cytoplasmic surfaces. These struc-
tures, called the inner and outer plaques, respectively, are
sites of microtubule association in vivo. The half-bridge,
thought to be a modification of the nuclear envelope, lies
next to the SPB on one side.
SPB duplication has been well characterized cytologi-
cally in wild-type and cell division cycle (
 
cdc
 
) mutant strains,
leading to a proposed morphological assembly pathway
(Byers and Goetsch, 1974; Winey and Byers, 1993). The
first visible step in the pathway is formation of the satel-
lite, a clump of electron-dense material found on the cyto-
plasmic surface of the half-bridge beside the existing SPB.
The satellite is thought to be the precursor of the new
SPB. This morphology is seen at Start, the point at which
cells make a commitment to either mate or enter another
round of division. After cells pass through Start, the SPB is
duplicated in a conservative manner. Identical side-by-side
SPBs are then seen, joined by a complete bridge structure.
The cycle is complete when the SPBs later separate to
form a short intranuclear spindle. These stages of duplica-
tion are also observed in various 
 
cdc
 
 mutants at the non-
permissive temperature, where the SPB cycle uniformly
arrests at a stage appropriate to other indicators of cell cy-
cle progression, such as budding and DNA synthesis. Mu-
tation of 
 
CDC28
 
 arrests cells at Start in G1 with a satellite-
bearing SPB, the same morphology that is seen when the
 
mating pheromone 
 
a
 
-factor is used to arrest cells at Start.
In contrast, side-by-side SPBs are found at 
 
cdc4
 
 or 
 
cdc34
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1. 
 
Abbreviations used in this paper
 
: 5-FOA, 5-fluoro-orotic acid; 
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, cell
division cycle; DIG, digoxigenin; ORF, open reading frame; ProA, protein
A; 
 
SMO1
 
, suppressor of mps one; SPB, spindle pole body; 
 
ts
 
, temperature
sensitive for growth.
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arrest, which occurs late in G1 (Byers and Goetsch, 1974;
Goebl et al., 1988).
A number of mutant strains have been identified that
are specifically defective in the SPB duplication event, fail-
ing in duplication and assembling a monopolar spindle.
The aberrant SPB structures formed in these strains have
been examined by electron microscopy. These morpholo-
gies, along with order-of-function experiments, indicate
where in the SPB duplication pathway each gene function
is required (Winey et al., 1991). 
 
CDC31
 
 and 
 
KAR1
 
 are ap-
parently required early in the pathway, possibly in deposi-
tion of the satellite, as mutations in these genes cause du-
plication to fail altogether (Byers, 1981
 
b
 
; Rose and Fink,
1987; Winey et al., 1991). 
 
MPS1
 
 is required for the transi-
tion from satellite-bearing to side-by-side SPBs; loss of
function produces a single, large SPB with an enlarged half-
bridge. 
 
MPS2
 
 and 
 
NDC1
 
 are required later in the path-
way. In 
 
mps2
 
 or 
 
ndc1
 
 mutants, duplication proceeds, but
the newly formed SPB is nonfunctional. It lacks an inner
plaque structure and is not properly inserted into the nu-
clear envelope (Winey et al., 1991, 1993).
Generally, these mutants proceed through G1 and S
phases at the nonpermissive temperature and transiently
arrest in G2 as large-budded cells with monopolar spin-
dles. However, cells carrying the 
 
mps1-1
 
 mutation behave
differently. Although SPB duplication has failed, these
cells exhibit no cell cycle arrest and go on to commit an ab-
errant mitosis that results in rapid loss of viability. 
 
MPS1
 
has been implicated in a mitotic checkpoint that responds
to spindle dysfunction by arresting the cell cycle (Hardwick
et al., 1996; Weiss and Winey, 1996). 
 
MPS1
 
 encodes an es-
sential protein kinase (Poch et al., 1994; Lauzé et al., 1995).
Significant sequence homology to the catalytic domains of
the mammalian dual specificity kinases PYT/TTK (Mills
et al., 1992; Lindberg et al., 1993) and 
 
esk
 
 (Douville et al.,
1992) suggests that the 
 
MPS1
 
 gene product, Mps1p, is it-
self a dual specificity kinase. In fact, Mps1p does auto-
phosphorylate serine, threonine, and tyrosine residues in
vitro (Lauzé et al., 1995).
We report here the identification of 
 
CDC37
 
 as a multi-
copy suppressor of the 
 
mps1-1
 
 temperature-sensitive (
 
ts
 
)
phenotype. In addition to multicopy suppressor interac-
tions, we find that alleles of 
 
CDC37
 
 and 
 
MPS1
 
 exhibit syn-
thetic lethal interactions. 
 
CDC37
 
 was originally isolated by
Reed (1980
 
a
 
) (Ferguson et al., 1986) in a screen for muta-
tions that cause cell cycle arrest at Start in G1 in a mating-
competent state, and a weak karyogamy defect is also seen
in 
 
cdc37
 
 mutants at the nonpermissive temperature (Dutcher
and Hartwell, 1982, 1983). Functional homologues of this
gene have recently been identified in 
 
Drosphilia melano-
gaster
 
 (Cutforth and Rubin, 1994) and mammals (Stepa-
nova et al., 1996), and the mammalian gene encodes a sub-
unit of the Hsp90 chaperone complex found in association
with several protein kinases (Stepanova et al., 1996). Phe-
notypic analysis demonstrates that 
 
cdc37-1
 
 arrest is a
novel Start arrest, where the SPBs have begun duplication
and formed an aberrant side-by-side structure, although
the cell remains mating pheromone responsive. One SPB,
apparently the newly formed one, displays an outer plaque
defect. Mutation of 
 
CDC37
 
 causes a loss of Mps1p kinase
activity but does not affect protein stability. These findings
demonstrate a requirement for 
 
CDC37
 
 function in normal
 
SPB duplication and may also suggest a more general role
for this gene in G1 control.
 
Materials and Methods
 
Yeast Strains, Cell Culture, and Genetic Techniques
 
The yeast strains used in this study are listed in Table I. Yeast culture and
genetic and molecular techniques were as described by Ausubel et al.
(1994). 
 
Escherichia coli
 
 DH5
 
a
 
 (Sikorski and Hieter, 1989) was cultured
and transformed as described by Ausubel et al. (1994). Yeast 5-fluoro-
orotic acid (5-FOA) plates were prepared and used as described by Boeke
et al. (1987) to select against yeast strains bearing a wild-type copy of the
 
URA3
 
 gene. The 
 
cdc37-1
 
 strain 5962-1-1b was successively outcrossed to
S288c-derived wild-type strains (Table I) until the G1 arrest phenotype of
cells shifted to the nonpermissive temperature behaved consistently, as
judged by budding index and flow cytometric determination of DNA con-
tent.
The 
 
mps1-1
 
 strain Wx241-17a was transformed with genomic libraries
constructed in the 2
 
m
 
 vectors YEp13 (Nasmyth and Tatchell, 1980) and
YEp24 (Carlson and Botstein, 1982). Approximately 12,000 YEp13 library
transformants and 96,000 YEp24 library transformants were obtained at
permissive temperature. These colonies were replica plated to rich (YPD)
medium at 30
 
8
 
C, the minimum nonpermissive temperature for this strain.
Ts
 
1
 
 transformants were identified and retested on YPD at 30
 
8
 
C. YEp24 li-
brary plasmids were then selected against on 5-FOA medium to identify
those isolates that depended upon the plasmid for growth at 30
 
8
 
C, and the
plasmids were transferred to 
 
E. coli
 
 for further analysis. For YEp13 li-
brary constructs, plasmid dependence was assessed by loss of the plasmid
during nonselective growth and subsequent testing for growth at 30
 
8
 
C.
In addition to 20 reisolations of 
 
MPS1
 
, four suppressor constructs were
isolated one or more times, for a total of 10 plasmids. Three contained
overlapping inserts: pN7 (isolated once), pC165 (isolated three times), and
pC166 (isolated five times; see Fig. 1), and they define the 
 
SMO1
 
 gene.
Creation of a variety of deletions in pC165 and pC166 narrowed the candi-
date region to the 
 
CDC37
 
 open reading frame (ORF). A frameshift muta-
tion at a unique BglII site early in the 
 
CDC37
 
 ORF in the deletion con-
struct pC166N
 
D
 
 (see Fig. 1) abolished suppression. Ability of multicopy
 
CDC37
 
 to suppress other 
 
mps1
 
 alleles was tested by transforming the
strains with pC166 and testing for growth on YPD at various tempera-
tures.
 
Cell Synchronization and Release from Arrest
 
Cells were arrested in G1 with 
 
a
 
-factor (7–10 
 
m
 
M) obtained by a custom
peptide synthesis using F-MOC chemistry on a peptide synthesizer (model
488; Applied Biosystems Inc., Foster City, CA). Efficiency of arrest was
monitored by budding index determination. Arrest was deemed successful
if 
 
.
 
90% of a briefly sonicated sample of 100–200 cells was unbudded and
was later confirmed by flow cytometric determination of DNA content.
Cells were rinsed and released from the arrest into growth medium with-
out 
 
a
 
-factor that was equilibrated to the temperature being used for the
release. Reentry into the cell cycle was monitored by budding index and
flow cytometry.
Cell cycle arrest of 
 
cdc37-1
 
, 
 
cdc37-1 mps1
 
, and 
 
cdc37-1 mps2-1
 
 strains
was accomplished in two ways. For experiments where cells were not pre-
pared for microscopy, asynchronous cultures were placed in fresh growth
medium equilibrated to 38
 
8
 
C and incubated for 8 h. Cell cycle arrest was
confirmed by budding index and flow cytometry as described above. In
some cases, cells were then released into fresh medium at 25
 
8
 
C, with or
without addition of 
 
a
 
-factor. Because long incubations at the high temper-
ature cause 
 
cdc37-1
 
 cells to become enlarged and fragile, care was taken
to minimize the time spent at 38
 
8
 
C when cells were to be prepared for
electron microscopy or indirect immunofluorescence. For such experi-
ments, cultures were prearrested in S phase at 25
 
8
 
C with 0.1 M hydrox-
yurea (Sigma Chemical Co., St. Louis. MO) until no unbudded cells re-
mained in a sample of 100–200 cells. When rinsed and released into 38
 
8
 
C
medium, this synchronous population traverses the cell cycle and reaches
G1 arrest after 6 h rather than 8 h.
 
Cytological Techniques
 
Yeast cells were prepared for flow cytometry as described by Hutter and
Eipel (1979) using the DNA stain propidium iodide (Sigma Chemical Co.). 
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Stained cells were analyzed on a Becton-Dickinson (Mountain View, CA)
FACScan
 
®
 
 flow cytometer using the LYSYS software package to obtain
and analyze data.
Yeast cells were prepared for thin sectioning as described by Byers and
Goetsch (1974, 1975). After sectioning, some sections were stained a sec-
ond time with uranyl acetate to increase contrast. Serial sections were
viewed on an electron microscope (model CM10; Phillips Electronic In-
strs. Co., Mahwah, NJ, or model 100 cx; JEOL, U.S.A. Inc., Peabody,
MA). Immunofluorescent staining of microtubules was performed as de-
scribed by Kilmartin and Adams (1984) as modified by Jacobs et al.
(1988), using the rabbit polyclonal serum 206-1 (anti–
 
b
 
-tubulin, kindly
provided by F. Solomon) (Bond et al., 1986).
 
Nucleic Acid Techniques
 
DNA was manipulated by standard techniques as described by Ausubel et al.
(1994). Plasmid DNA was prepared from 
 
E. coli
 
 with Wizard prep kits (Pro-
mega Corp., Madison, WI) and from yeast as described by Hoffman and
Winston (1987). DNA sequencing was performed with a Sequenase 2.0 kit
(United States Biochemical Corp., Cleveland, OH) according to instruc-
tions provided by the supplier. To determine the identity of the 
 
SMO1
 
gene, limited sequencing was performed using pSMO1-LEU2 as template.
A T7 sequencing primer was used to sequence from the pRS305 poly-
linker into the insert, beginning at the unique BglII site in the 
 
CDC37
 
gene and proceeding toward the 3
 
9
 
 end.
DNA hybridization was performed with a BglII fragment containing
most of the 
 
CDC37
 
 ORF and several kilobases of 3
 
9
 
 flanking sequence.
DNA was labeled by random-primed incorporation of digoxigenin (DIG)–
labeled deoxyuridine triphosphate and detected with the Genius System
(Boehringer Mannheim Corp., Indianapolis, IN) as recommended by the
supplier. The probe was hybridized to the Olson collection of overlapping
genomic clones (Riles et al., 1993; American Type Culture Collection,
Rockville, MD) in 5
 
3
 
 SSC, 50% deionized formamide, 5% (wt/vol) Ge-
nius blocking reagent, 0.1% 
 
N
 
-lauroylsarcosine (sodium salt), and 0.02%
SDS at 42
 
8
 
C for 16 h. Anti-DIG antibody conjugated to alkaline phos-
phatase was bound to hybridized DIG-labeled DNA and detected by ap-
plication of the chemiluminescent substrate Lumiphos 530.
To construct the integrant strain used for genetic mapping, the same
BglII fragment was cloned into the integrative 
 
LEU2
 
-marked vector
pRS305 (Sikorski and Hieter, 1989) at the BamHI site to create pSMO1-
LEU2. This plasmid was linearized at a unique NheI site in the insert and
used to transform the wild-type strain Wx257-2b (Table I). Proper integra-
tion was confirmed by genomic Southern blotting analysis. This strain was
crossed to the 
 
cdc37-1
 
 strain AS138-11a (Table I), and tetrads were dis-
sected to examine the linkage of the 
 
LEU2
 
 marker to 
 
cdc37-1.
 
Protein A Tagging of MPS1
 
The genomic copy of 
 
MPS1
 
 was tagged by COOH-terminal in-frame inte-
gration of a fragment of the protein A gene encoding the IgG-binding do-
mains, as described in Aitchison et al. (1995). Two primers were designed
and used in PCR amplification from the protein A (ProA)/HU plasmid.
The first primer (MPS1S) corresponds to the final 69 bp of the ORF of
 
MPS1
 
 (nucleotide numbers 2692–2762) and nucleotides 421–441 of the
protein A ORF. Sequence of MPS1S: 5
 
9
 
-CCA CAT ATA TCA CAA
GAT GAT CTC AAT GAT GTG GTA GAC ACT GTT TTA AGG
AAA TTT GCA GAT TAC AAA ATT GGT GAA GCT CAA AAA
CTT AAT-3
 
9
 
. The second primer (MPS1U) contains the reverse comple-
 
Table I. Yeast Strain List
 
Strain Genotype Source
5962-1-1b a cdc37-1 his4 ade2 lys2 trp1 tyr1 SUP4 B. Byers*
AS126-2b a mps1-1237 ura3-52 leu2-3, 112 his3D200 This study‡
AS138-11a a cdc37-1 leu2-3, 112 ade2 This study
AS146-1b a cdc37-1 mps1-1 ura3-52 leu2-3, 112 hisD200 trp1D1; pC166ND (CDC37-URA3-2m) This study
AS146-26b a cdc37-1 ura3-52 leu2-3, 112 lys2 This study
AS151-4a a cdc37-1 mps1-737 ura3-52 leu2-3, 112 his3D200 This study‡
AS153-12d a cdc37-1 mps1-1237 ura3-52 leu2-3, 112 lys2 This study‡
AS156-3b a cdc37-1 mps1-412 ura3-52 leu2-3, 112 trp1D1 lys2 This study§
AS157-10a a cdc37-1 mps1-3796 ura3-52 leu2-3, 112 This studyi
AS158-2a a cdc37-1 ura3-52 leu2-3, 112 his3D200 lys2 This study
AS164-13a a cdc37-2 mps1-737 ura3-52 leu2-3, 112 lys2 aro1 This study‡
AS165-3a a cdc37-2 mps1-1237 ura3-52 leu2-3, 112 his3D200 aro1 This study‡
AS166-5b a cdc37-2 mps1-412 ura3-52 leu2-3, 112 trp1 aro1 This study§
AS167-6b a cdc37-2 mps1-3796 ura3-52 leu2-3, 112 his3D200 trp1 This studyi
AS171-3b a cdc37-2 mps1-1 ura3-52; pC166ND (CDC37-URA3-2m)
AS177-11b a cdc37-1 mps2-1 ura3-52 leu2-3, 112 This study
AS177-11b/p37 a cdc37-1 mps2-1 ura3-52 leu2-3, 112; pC166ND (CDC37-URA3-2m) This study
AS217-5b a cdc37-1 mps1-6 ura3-52 leu2-3, 112 This study¶
AS218-9c a cdc37-2 mps1-6 ura3-52 trp1D1; pC165 (CDC37-URA3-2m) This study¶
AS230-7a a URA3-GAL1-NmycMPS1 leu2-3, 112 his3D200 trp1D1 ade2 This study
AS230-7b a cdc37-1 URA3-GAL1-NmycMPS1 leu2-3, 112 his3D 200 trp1D 1 ade2 This study
AS231-2b a cdc37-1 URA3-HIS3-ProA-MPS1 leu2-3, 112 This study
AS231-2d a URA3-HIS3-ProA-MPS1 leu2-3, 112 This study
D8BX5CA a/a ura3-52/ura3-52 leu2-3, 112/leu2-3, 112 his3D200/his3D200 trp1D1/trp1 D1 This study 
S288c a gal2 R.K. Mortimer**
SR674-2 a cdc37-2 hom2 arol arg4 trp1 S.I. Reed‡‡
Wx241-17a a mps1-1 ura3-52 leu2-3, 112 his3D200 This study
Wx257-2b a ura3-52 leu2-3, 112 trp1D1 This study
Wx257-2d a ura3-52 leu2-3, 112 his3D200 This study
Wx257-4c a ura3-52 leu2-3, 112 his3D200 This study
*University of Washington, Seattle, WA.
‡These mps1 alleles originally isolated by E.A. Siewert, University of Colorado, Boulder, CO.
§This mps1 allele originally isolated by J.V. Kilmartin, MRC, Cambridge, England.
iThis mps1 allele originally isolated by T. Huffaker, Cornell University, Ithaca, NY.
¶This mps1 allele originally isolated by D. Koshland, Carnegie Institute of Washington, Baltimore, MD.
**University of California, Berkeley, CA.
‡‡Scripps Research Institute, La Jolla, CA.The Journal of Cell Biology, Volume 136, 1997 972
ment sequences of the 39 untranslated region of MPS1, from nucleotide
number 2868–2930, and the reverse complement sequences of the URA3
gene (nucleotide numbers 1027–1050). Sequence of MPS1U: 59-GTA
TTC AGT GTC TGT GAC GAA AAA TTG ATT GAT GAT TTA
TTT AAA TGA ATA TAT ATA AAT TAG TTT ACT TAT AAT TCT
GTT TTT TAG-39.
The PCR product was gel purified and ethanol precipitated and then
transformed directly into the haploid yeast strains Wx257-2d and Wx257-
4c, or the diploid strain D8BX5CA (Table I). Transformants were verified
by Western blot against the protein A tag using rabbit IgG (Sigma Chemi-
cal Co.) as primary antibody, by PCR with primers to MPS1 and HIS3,
and by linkage to mps1-1.
Protein Techniques and Kinase Assays
To examine ProA-Mps1p stability, cells carrying the tagged allele were
grown at the appropriate temperatures and then lysed in 13 Laemmli
sample buffer (Ausubel et al., 1994) by vortexing with 0.45–0.52-mm glass
beads for 5 min at 48C. Lysates were separated on 8% SDS-PAGE gels
(Ausubel et al., 1994) and then electrophoretically transferred to Immo-
bilon membranes (Millipore Corp., Bedford, MA). ProA-Mps1p was
detected on Western blots with rabbit IgG as primary antibody and a
horseradish peroxidase–conjugated secondary antibody using the ECL
chemiluminescent system (Amersham Corp., Arlington Heights, IL). The
half-life of myc-Mps1p was examined by inducing expression of the tagged
gene with 4% galactose for 6 h at 258C to create a pool of tagged protein
(Hardwick et al., 1996). Glucose was then added to the culture at 2% to
repress the promoter, and half the cells were transferred to 388C medium.
Cell lysates were made and protein stability monitored by Western blot as
described for ProA-Mps1p, except that the anti-myc 9E10 antibody (Evan
et al., 1985) was used. For both ProA-Mps1p and myc-Mps1p Western
blots, equal protein loadings on SDS-PAGE gels were confirmed by stain-
ing of duplicate gels with Coomassie brilliant blue.
For ProA-Mps1p kinase assays, cultures were grown at 258 or 388C, and
6 3 108 cells were collected for each assay. Cells were disrupted by vortex-
ing for 5 min at 48C in 0.5 ml buffer B (Lauzé et al., 1995) with 300 ml glass
beads. The lysate was clarified by centrifuging for 10 min at 13,000 g at
48C, and the supernatant was incubated with 5% IgG-Sepharose (Pharma-
cia LKB Biotechnology, Piscataway, NJ) for 2 h at 48C. The resin was then
washed three times in buffer B, five times in TST (50 mM Tris-HCl, pH
7.6, 150 mM NaCl, 0.05% Tween-20), and three times in nondetergent
buffer (Lauzé et al., 1995). Immunoprecipitated material was used for ki-
nase assays as described in Lauzé et al. (1995), except that reactions were
carried out for 20 min. To quantitate ProA-Mps1p, a small amount of ly-
sate (described above) was separated on SDS-PAGE gels. Proteins were
transferred to Immobilon and detected with rabbit IgG as primary anti-
body, followed by alkaline phosphatase secondary antibody and the quan-
titative chemiluminescent substrate Attaphos (JBL Scientific, San Luis
Obispo, CA). Autoradiograms and Western blots were scanned using a
phosphorimager (model Storm 860; Molecular Dynamics, Sunnyvale, CA)
and quantitated with the ImageQuaNT analysis package.
Results
Isolation of Multicopy Suppressor Plasmids
Yeast genomic libraries constructed in the multicopy 2m
vectors YEp13 and YEp24 (see Materials and Methods)
were transformed into an mps1-1 mutant strain that is ts
for growth (Wx241-17a; Table I). Plasmids that conferred
growth at 308C, the lower limit of the nonpermissive tem-
perature for mps1-1, were identified. Only constructs con-
taining wild-type MPS1 enabled growth at temperatures
above 308C. In addition to MPS1 itself, four constructs
were identified that could suppress the mutation. Three of
these (pN7, from the YEp13 library; and pC165 and
pC166, from the YEp24 library) were found by restriction
digest to contain overlapping inserts. Restriction maps for
pC165 and pC166 are shown in Fig. 1. The gene common
to these was designated suppressor of mps one (SMO1).
The fourth was unique and was designated SMO2. Be-
cause pN7, pC165, and pC166 were stronger suppressors,
conferring better growth at 308C than pN8 (SMO2), this
group was chosen for further study.
CDC37 Is a Multicopy Suppressor of mps1-1
Deletion of regions from the pC165 and pC166 genomic
inserts identified a 3.5-kb region required for suppression
(Fig. 1). A probe from this region was physically mapped
by hybridization to the overlapping set of l genomic clones
(Riles et al., 1993). This mapped SMO1 to the Olson clones
5879 (American Type Culture Collection clone 70620) and
5219 (American Type Culture Collection clone 70543), on
the right arm of chromosome IV. A frameshift mutation
created by filling in and religation of a unique BglII site in
pC166ND destroyed suppressor activity (Fig. 1). DNA se-
quence analysis of the region adjacent to this BglII site re-
vealed that the suppressor activity is encoded by the
CDC37 gene.
The physical map position on chromosome IV is consis-
tent with the genetic map position of CDC37. Further con-
firmation of the identity of the gene was achieved in two
ways. First, p166ND (Fig. 1) was transformed into a cdc37-1
mutant strain (5962-1-1b; Table I) and fully complemented
Figure 1. SMO1 suppressor
activity is provided by the
CDC37 ORF. For the dele-
tion (D) constructs, SphI and
NheI sites from the vector
were used to delete portions
of the insert. The asterisk in-
dicates the position of the
frameshift mutation created
in p166NDBfs (Materials and
Methods). Restriction en-
zyme sites: B, BglII; N, NheI;
S, SphI. Suppression of
mps1-1 was assessed by the
ability of Wx241-17a (Table
I) to grow at 308C, and com-
plementation of the cdc37-1
mutation was assessed in
AS138-11a (Table I) at 388C.Schutz et al. Yeast CDC37 Gene 973
the ts phenotype. Second, the BglII fragment from pC165
(Fig. 1) was placed in the integrative LEU2 vector pRS305
(Sikorski and Hieter, 1989) to create pSMO1-LEU2. This
construct was linearized and transformed into the wild-
type strain Wx257-2b (Table I) to be integrated at the
SMO1 locus. The resulting strain was crossed to cdc37-1
(AS138-11a; Table I), and the integrated LEU2 marker
behaved tightly linked to cdc37-1 as expected (data not
shown). 
In addition to the mps1-1 allele used for the suppressor
screen, several other alleles of this gene are available. A
group of ts isolates was identified based upon their failure
to complement the mps1-1 mutation. An x-ray–induced mi-
totic recombination assay (Mannis and Mortimer, 1964)
was used to divide these isolates into recombination groups,
defining a total of at least six distinct alleles: mps1-1,
mps1-6, mps1-737, mps1- 1237, mps1-412, and mps1-3796.
Multicopy CDC37 was able to suppress only one other al-
lele, mps1-1237 (Table I), and that suppression was weak;
these cells grew very poorly at 348C, which is the minimum
nonpermissive temperature for mps1-1237 strains. The
ability of CDC37 to act as a bypass suppressor of a mps1
disruption allele was also tested. A 2m CDC37 plasmid
could not rescue the inviability of strains carrying a HIS3-
marked disruption allele (Lauzé et al., 1995), indicating
that CDC37 does not bypass the requirement for MPS1 in
mitotic growth.
Two ts alleles of CDC37 have previously been identi-
fied, each causing cdc arrest at Start in the G1 phase of the
cell cycle (Reed, 1980a, b). We used these alleles to look
for additional genetic evidence that MPS1 and CDC37 in-
teract. We found that multicopy MPS1 was unable to sup-
press the ts phenotype of cdc37-1 or cdc37-2. Double mu-
tant strains were constructed between the two alleles of
CDC37 and the six alleles of MPS1 to look for synthetic
phenotypes (Table I). These double mutant strains exhib-
ited synthetic phenotypes of varying severity (Table II).
Combination of the mps1-1 allele with either cdc37-1 or
cdc37-2 was lethal, as was combination of mps1-6 with
cdc37-2. When haploid strains carrying these mps1 muta-
tions were mated to cdc37-1 or cdc37-2 haploids and the
resulting diploids were sporulated, no viable double mu-
tant segregants were obtained. If the same mps1/MPS1
cdc37/CDC37 diploids were transformed with a 2m URA3
plasmid bearing CDC37 before sporulation, double mu-
tant segregants could be generated, but these strains were
dependent on the plasmid for survival (assayed by inabil-
ity to grow on 5-FOA medium). Double mutant combina-
tions between mps1-6 and cdc37-1, or between mps1-737
and either cdc37 allele, showed enhanced temperature
sensitivity; the nonpermissive temperature for these strains
was lowered by several degrees compared to that for each
allele alone. These strains also grew very slowly at room
temperature. Combination of mps1-1237 or mps1-3796
with cdc37-2 also caused enhanced temperature sensitiv-
ity, but these strains grew normally at room temperature.
The remaining combinations of alleles caused no synthetic
phenotypes.
Side-by-side SPBs Are Found at cdc37-1 Arrest
Like MPS1, the CDC37 gene might be required for proper
SPB duplication. To address this, we examined the state of
the SPB at cdc37-1 arrest by electron microscopy of serial
thin sections. We initially expected to see a single SPB
with a satellite in each cell (Fig. 2 a). The cdc37-1 mutation
was originally identified by its ability to arrest the cell cy-
cle at Start in G1, with the characteristic “shmoo” mor-
phology seen in cells responding to mating pheromone
(Reed, 1980a), and we have confirmed this G1 arrest in
our strains by cell morphology and flow cytometric analy-
sis of DNA content (data not shown). Such a Start arrest is
ultrastructurally defined by the presence of a satellite-
bearing SPB (Byers and Goetsch, 1974, 1975). These cells
are also reportedly somewhat competent to mate at the ar-
rest (Reed, 1980a), which implies the presence of the sin-
gle satellite-bearing SPB structure normally required to
participate in karyogamy (Byers and Goetsch, 1975).
When cdc37-1 cells (AS158-2a; Table I) were incubated
at the nonpermissive temperature and the nuclei exam-
ined by electron microscopy, we found duplicated side-by-
side SPBs joined by a full bridge structure, distinct from
the expected satellite-bearing SPBs (Fig. 2, c–e). Of 15 nu-
clei examined, 14 contained clear side-by-side SPBs and
one contained a spindle, consistent with the degree of G1
arrest seen in this experiment by flow cytometry and bud-
ding index (data not shown). Although the cells were pre-
sumably arrested at Start, their SPBs had proceeded past
that point.
Upon examination of a number of side-by-side SPBs
from cells at cdc37 arrest, it became apparent that the
structure was not completely normal. Although one SPB
in each cell appeared intact and all of its expected struc-
tures were seen, this was not true of the other. The second
SPB had a defective outer plaque structure, which was ab-
sent in some nuclei and reduced to varying degrees in oth-
ers. Examples of the range of this phenotype are shown in
Fig. 2, c–e. For comparison, an example of normal side-by-
side SPBs is shown in Fig. 2 b. The single outer plaque ob-
served on one SPB at cdc37-1 arrest was much more prom-
inent than that seen in wild-type or cdc37-1 cells grown at
258C, suggesting that accumulation of excess outer plaque
material is an aspect of this mutant phenotype. Continued
incorporation of material into the SPB and half-bridge
during incubation at the nonpermissive temperature has
previously been observed in monopolar spindle mutants
(Byers, 1981a; Winey et al., 1991); some of these display
Table II. Synthetic Growth Phenotypes of cdc37 mps1
Double Mutants
mps1 allele
cdc37 allele
cdc37-1 cdc37-2
mps1-1 lethality* lethality*
mps1-6 enhanced ts‡ lethality*
mps1-412 none none
mps1-737 enhanced ts‡ enhanced ts‡
mps1-1237 none enhanced ts‡
mps1-3796 none enhanced ts‡
Strain names and genotypes are listed in Table I.
*These strains are inviable and can only be cultured when one wild-type gene is
present on a plasmid.
‡The nonpermissive temperature of these strains is lowered by several degrees rela-
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very prominent outer plaques. Viability of cdc37-1 cells re-
mained high after 8 h at the nonpermissive temperature.
When cells were then plated at the permissive tempera-
ture, they recovered from arrest with a haploid DNA con-
tent, suggesting that the aberrant SPB structure could
somehow be completed or circumvented and a functional
spindle could be assembled to carry out nuclear division.
cdc37-1 Arrest Is Interdependent with Start
Since the presence of duplicated side-by-side SPBs in
these cells seemed at odds with their previously reported
arrest at Start, we reexamined the cdc37-1 arrest pheno-
type to determine if it was consistent with a Start arrest.
Reed (1980a) used a reciprocal shift experiment to exam-
ine where the cdc37 arrest point lies in the cell cycle, rela-
tive to Start. However, the Coulter counter measurements
of cell number used to track cell cycle progression did not
demonstrate clear cell cycle arrest, possibly because cdc37
cells become elongated and may fragment during long in-
cubations at the nonpermissive temperature. We repeated
this experiment using flow cytometric determination of
DNA content as a potentially more accurate way to deter-
mine if cells proceeded through the cycle into S phase or
remained arrested.
This reciprocal shift experiment (see Hereford and
Hartwell, 1974) made use of the mating pheromone a-fac-
tor, which causes MATa cells to arrest in G1 at Start, the
point where cells make a commitment to mate or enter the
next round of mitotic division. Mating pheromone revers-
Figure 2. cdc37-1 causes an aberrant SPB phenotype. (a) Schematic representation of the SPB duplication pathway (after Byers, 1981a).
The outer and central plaques are shown, and microtubules are depicted only on the nuclear surface of the SPB to show orientation. (b)
Normal side-by-side SPB structure seen in a cdc37-1 mutant strain (AS158-2a; Table I) grown at 258C, the permissive temperature. One
complete outer plaque (arrow) and part of the second have been captured in this section. OP, outer plaque; CP, central plaque; B,
bridge. The inner plaque is difficult to see under these fixation and staining conditions. (c–e) Side-by-side SPB structures seen in a
cdc37-1 mutant strain (AS158-2a; Table I) incubated at 388C for 6 h. One prominent outer plaque is present in each cell (arrows). In e, a
small amount of outer plaque material can be seen on the second SPB (arrowhead). In each case (c–e), examination of serial sections ad-
jacent to the sections shown here revealed no additional outer plaque material. Bars, 0.2 mm.
Figure 3. Reciprocal shift data indicate that the
cdc37-1 arrest point is interdependent with Start.
(a) A cdc37-1 strain (AS158-2a; Table I) was ar-
rested in G1 by incubation at 388C for 8 h and
then released at 258C in the presence of a-factor.
Samples were taken for flow cytometry at the ar-
rest (0 h) and at 1-h intervals (1 h–4 h). These cells
remain G1-arrested. In the control (C; filled
curve), arrested cells were released at 258C with
no a-factor and sampled at 4 h. These cells have
a 2 N DNA content; they have recovered from
cdc37 arrest and moved into G2/M. After 9 h at
the permissive temperature, the population has
completely recovered and displays a normal cell
cycle distribution (not shown). (b) The same
strain was arrested at Start with a-factor at 258C and then released from this arrest at 388C. Samples were taken at the arrest (0 h) and at
1-h intervals (1 h–4 h). The cells again remain G1 arrested. Drifting of the G1 peak to the right is eliminated when the experiment is per-
formed with rho8 derivatives of AS158-2a, indicating that the drift results from accumulation of mitochondrial DNA as the cells become
enlarged, not from progression into S phase (not shown). In the control (C; filled curve), a-factor–arrested cells were released at 258C
and sampled at 4 h. The cells have recovered from a-factor arrest and show a typical G1 and G2/M distribution of DNA content. In
these histograms, the x-axis is the relative DNA content determined by propidium iodide fluorescence, and the y-axis is the relative
number of cells (Materials and Methods). Each sample represents 10,000 cells.Schutz et al. Yeast CDC37 Gene 975
ibly blocks SPB duplication at the satellite-bearing SPB
stage (Fig. 2 a). The reciprocal shift used two distinct
methods to block the cell cycle, a-factor and cdc37 arrest,
first in one order and then in the reciprocal order. Behav-
ior of the cells in response to these manipulations allows
us to compare the timing of a-factor arrest relative to
cdc37 arrest. For the first shift, a population of log phase
cdc37-1 cells (AS158-2a; Table I) was arrested in G1 by in-
cubation at the nonpermissive temperature. The cells were
then returned to the permissive temperature in the pres-
ence of an excess of a-factor. Cell cycle progression was
monitored by flow cytometric analysis of DNA content
and by cell morphology. In this experiment, the cells re-
mained arrested in G1 (Fig. 3 a), indicating that the cdc ar-
rest point must be before or equivalent to a-factor arrest.
In the reciprocal experiment, log phase cultures of the
same strain were exposed to a-factor at room temperature
to arrest them at Start. Cells were then removed from mat-
ing pheromone and placed at the nonpermissive tempera-
ture, and cell cycle progression was monitored as de-
scribed above. The cells remained arrested in G1 (Fig. 3 b),
indicating that the arrest must be subsequent or equivalent
to a-mating pheromone arrest. Integration of data from
both halves of the reciprocal shift confirms the previous
observation that the cdc37-1 arrest point is equivalent to,
or interdependent with, Start. However, because of the
duplicated or partially duplicated nature of the SPBs, this
represents a novel Start arrest.
Epistatic Relationship between CDC37 and MPS1
Although CDC37 and MPS1 have been found to interact
genetically, mutations in these two genes have distinct cell
cycle and SPB phenotypes. The epistatic relationship be-
tween cdc37 and mps1 was examined with respect to both
phenotypes. All eight viable combinations between cdc37-1
and the six alleles of mps1 (Table II) were shifted to the
nonpermissive temperature to examine their cell cycle phe-
notype. An mps1 single mutant strain shows no delay in
cell cycle progression at high temperature (Winey et al.,
1991). In contrast, all cdc37-1 mps1 double mutant strains
arrested in G1 as a cdc37-1 single mutant would (Fig. 4 a).
Thus, cdc37-1 is epistatic to mps1 for cell cycle phenotype.
SPB morphology was examined in one of these strains, a
cdc37-1 mps1-1237 double mutant (AS153-12d; Table I).
The double mutant strain was incubated at the nonpermis-
sive temperature, and nuclei were examined by electron
microscopy. These cells exhibited the mps1 phenotype
(Fig. 4, b and c); only one SPB was present, and it lay adja-
cent to an enlarged and clearly visible half-bridge (Fig. 4 c,
arrow; n 5 9). Thus, the epistasis for SPB morphology is
reversed compared to cell cycle behavior. Both of the epi-
static relationships described are consistent with the exe-
cution points for these two genes.
The Outer Plaque of the Newly Formed SPB
Is Defective
Since asymmetry was observed between the two SPBs at
cdc37-1 arrest, with one being normal and the other defec-
tive, we reasoned that the defect might be specific to either
the old or new SPB. It seemed likely that the newly
formed SPB would be the defective one, given that the ex-
Figure 4. The epistatic relationship between mps1-1237 and
cdc37-1 is different for different phenotypes. (a) An asynchro-
nous culture of the mps1-1237 cdc37-1 double mutant strain
AS153-12d (Table I) was shifted to 388C, and cell cycle distribu-
tion was monitored by flow cytometry. Samples were taken be-
fore the shift (0 h) and at 2-h intervals (2 h–8 h). These cells ex-
hibit the cdc37-1 phenotype; they arrest in G1. A similar G1
arrest is seen in double mutant strains that carry other alleles of
mps1. The drift of G1 and G2/M peaks to the right at later time
points is attributed to accumulation of mitochondrial DNA as the
cells become enlarged. The x-axis is the relative DNA content de-
termined by propidium iodide fluorescence, and the y-axis is the
relative number of cells (Materials and Methods). Each sample
represents 5,000 cells. (b) Schematic representation of the mps1
SPB phenotype. (c) The same mps1-1237 cdc37-1 strain was incu-
bated at 388C for 6 h and examined by EM. These cells display
the typical mps1 phenotype: a single SPB, with an enlarged half-
bridge (arrow). Bar, 0.2 mm.The Journal of Cell Biology, Volume 136, 1997 976
isting SPB had been assembled before CDC37 function
was lost and presumably remained intact. To test this idea,
we made use of the mps2-1 mutation (Winey et al., 1991)
to distinguish between the existing and newly formed
SPBs. In mps2-1 strains at the nonpermissive temperature,
one SPB is completely normal, but the other—the new
SPB—is morphologically distinct. This SPB lacks an inner
plaque structure, is not properly inserted into the nuclear
envelope (Fig. 5 a), and nucleates only cytoplasmic micro-
tubules. At early time points after shift to the nonpermis-
sive temperature, the mps2 defective SPB can be seen
perched on the end of the half-bridge, on its cytoplasmic
face. Fig. 5 b shows an example of this morphology in an
mps2-1 cdc37-1 double mutant strain with the cdc37 muta-
tion complemented by a wild-type copy of this gene on a
plasmid (AS177-11b/p37; Table I). In response to this
spindle defect, mps2-1 cells arrest in G2.
When an mps2-1 single mutant strain is shifted to the
nonpermissive temperature, the defective SPB eventually
migrates away from its sibling to a distal location on the
nuclear envelope periphery. The defective SPB is easily
detected in these cells because its cytoplasmic microtu-
bules are seen as a second focus of staining when microtu-
bule organization is observed by immunofluorescent stain-
ing of tubulin (Winey et al., 1991). We examined tubulin
staining patterns in an mps2-1 cdc37-1 double mutant
strain (AS177-11b; Table I) shifted to the nonpermissive
temperature to see if the second focus of staining was af-
fected by the cdc37 mutation. If formation of the outer
plaque on the defective SPB was disrupted, the structure
would no longer be competent to nucleate microtubules.
At all time points, only one focus of staining was observed,
with the long cytoplasmic microtubule arrays characteris-
tic of a Start arrest (data not shown). This observation sug-
gests that the formation or function of the mps2 defective
SPB has been impaired. When the same strain was trans-
formed with CDC37 on a plasmid and then shifted to the
nonpermissive temperature, a typical mps2 mutant tubulin
staining pattern with two foci was restored (data not
shown), and the mps2 SPB phenotype was seen by elec-
tron microscopy (as in Fig. 5 b), indicating that back-
ground effects in the double mutant strain are not contrib-
uting to the phenotype.
To further explore the SPB phenotype, the double mu-
tant strain was shifted to the nonpermissive temperature,
and SPB morphology was examined by electron micros-
copy. The cells arrest in G1; cdc37-1 is epistatic to mps2-1
for cell cycle phenotype (data not shown). Proper position
in the nuclear envelope was used to differentiate the old
SPB from the new (Fig. 5). By this method we were able to
assign the outer plaque defect specifically to the newly
formed SPB. In each cell (n 5 14), one normal SPB was
seen residing within the nuclear envelope, bearing an obvi-
ous outer plaque (Fig. 6), leading us to conclude that the
existing SPB is unaffected by the cdc37-1 mutation. No
other clear SPB structure was present. Instead, a clump of
electron-dense material, similar to a satellite but larger,
was often seen near the open end of the half-bridge (Fig. 6,
arrowheads). This clump varied in size, and in some cases
appeared more diffuse than others. We suggest that this
clump may represent the remnants of the typical mps2
defective SPB. Migration of this clump away from its sibling
SPB was not detected by electron microscopy. Movement
of the defective SPB to a distal location in an mps2 single
mutant is attributed to cytoplasmic microtubules, and
these are absent in the double mutant cells. These obser-
vations suggest that CDC37 gene function is required for
successful formation of the new SPB.
The cdc37-1 Mutation Affects Mps1 Kinase Activity
Loss of CDC37 function has previously been shown to af-
fect the stability of two protein kinases in budding yeast,
Cdc28p (Gerber et al., 1995) and the heterologously ex-
pressed oncogenic tyrosine kinase pp60v-src (Boschelli et al.,
1993; Dey et al., 1996b). For Cdc28p, reduced steady-state
levels of the protein have been observed in a cdc37-1 back-
ground (Gerber et al., 1995). We examined the effect of this
mutation on Mps1p stability. To do this, Mps1p was tagged
at its COOH terminus with the IgG-binding domains of
Staphylococcus aureus protein A. This was achieved by in-
tegration of the protein A coding sequence into the chromo-
somal copy of MPS1 just before the stop codon, creating a
single-copy tagged allele expressed from the endogenous
promoter (Aitchison et al., 1995; see Materials and Meth-
ods). The resulting ProA-Mps1p fusion protein was func-
tional; haploid strains that carried only this allele of MPS1
grew normally (data not shown). Endogenous levels of
ProA-Mps1p could be detected by Western blotting of
whole cell lysates using rabbit IgG as the primary antibody
(Materials and Methods). Steady-state levels of ProA-
Figure 5. The mps2 mutation causes failure of SPB duplication at
a later stage. This phenotype is depicted schematically in a. The
old and new SPBs can be distinguished by their location relative
to the nuclear envelope and by the absence of nuclear microtu-
bules on the new (defective) SPB. (b) An mps2-1 cdc37-1 strain
carrying the wild-type CDC37 gene on a plasmid (AS177-11b/p37;
Table I) was incubated at the nonpermissive temperature for 4 h
and examined by EM. In this micrograph, the new, defective SPB
(arrow) has not yet migrated away from its sibling. Bar, 0.2 mm.Schutz et al. Yeast CDC37 Gene 977
Mps1p were not affected by the cdc37-1 mutation, even af-
ter extended incubation at the nonpermissive temperature
(Fig. 7 a).
It has recently been shown that inactivation of the mam-
malian homologue of Cdc37p markedly reduces the half-
life of the Cdk4 kinase (Stepanova et al., 1996). Because of
this result, we examined specifically the contribution of
half-life to steady-state levels of Mps1p in wild-type and
cdc37-1 cells. This experiment made use of a functional,
galactose-inducible myc-tagged MPS1 allele (Hardwick et
al., 1996). Wild-type and cdc37-1 cells (AS230-7a and
AS230-7b, respectively; Table I) were given a 6-h “pulse”
of galactose to induce myc-Mps1p, then “chased” by trans-
fer to medium containing glucose to repress the promoter,
and incubated at permissive and nonpermissive tempera-
tures. Stability of myc-Mps1p after the “chase” was moni-
tored by Western blotting with anti-myc antibody. Muta-
tion of CDC37 did not significantly alter the half-life of
myc-Mps1p at either temperature (Fig. 7 b). Intriguingly,
we found that incubation of the wild-type strain at high
temperature caused a modest but reproducible increase in
the amount of myc-Mps1p that remained after 6 h of chase
(Fig. 7 b), suggestive of some type of a heat shock re-
sponse contribution to protein stability. We also examined
galactose-induced accumulation of myc-Mps1p in cdc37-1
strains induced at the nonpermissive temperature, but we
discovered that this mutation causes a general defect in ga-
lactose-induced expression similar to that reported for
mutations in YDJ1 (data not shown; Dey et al., 1996a).
Beyond its effect on kinase stability, a requirement for
CDC37 to promote the enzymatic activity of protein ki-
nases has been observed; for example, Cdc28p kinase ac-
tivity is reduced two- to threefold in a cdc37-1 strain (Ger-
ber et al., 1995). With this observation in mind, we
examined the effect of the cdc37-1 mutation on Mps1p ki-
nase activity, using the protein A–tagged allele described
above. In this experiment, we assayed ProA-Mps1p kinase
activity from wild-type and cdc37-1 cells growing at the
permissive temperature, and after 1 h of incubation at the
nonpermissive temperature. This high-temperature incu-
bation was kept brief to avoid caveats arising from the dif-
ferent cell cycle distributions of actively growing wild-type
cultures and cdc37-1 cultures that are becoming arrested
in G1. Kinase assays were performed with material immu-
noprecipitated from wild-type and mutant cells (AS231-2d
and AS231-2b, respectively; Table I). Activity was then
quantitated with a phosphorimager and normalized for the
amount of ProA-Mps1p present in the lysates as deter-
mined by Western blotting with rabbit IgG (Materials and
Methods).
Figure 6. mps2-1 cdc37-1 cells display a synthetic SPB pheno-
type. The mps2-1 cdc37-1 strain AS177-11b (Table I) was incu-
bated at 388C for 6 h and examined by EM. In each cell, one SPB
appears normal and intact. Adjacent to each half-bridge is a
clump of material that may constitute the remnants of the new
SPB (arrowheads). This clump varies somewhat in size and
shape. In a and b, the entire structure has been captured in one
thin section. Each of the remaining pairs of images (c1 and c2; d1
and d2; and e1 and e2) is a set of adjacent serial sections through a
single nucleus, where part of the SPB structure was captured in
the first section and the remainder can be seen in the next sec-
tion. Bars: (a) 0.1 mm; (c1–e2), 0.2 mm.The Journal of Cell Biology, Volume 136, 1997 978
This analysis demonstrated that autophosphorylation by
ProA-Mps1p was compromised in cdc37-1 cells, even when
these cells were growing at the permissive temperature
(Fig. 8 a). Kinase activity in lysates of cdc37-1 cells was two-
to threefold lower than in lysates of wild-type cells. After 1 h
at the nonpermissive temperature, cell cycle distribution
in the mutant culture was not yet appreciably affected
(Fig. 8 b), but kinase activity was reduced even further, to
a level four- to fivefold less than that seen in wild-type ly-
sates, a more dramatic effect than reported for Cdc28p
(Gerber et al., 1995). This difference in kinase activity was
emphasized by the appearance of other, slower-migrating
species in the wild-type assays (Fig. 8 a, bracket). Substan-
tial autophosphorylation by Mps1p fusion proteins pro-
duces higher molecular weight forms of the protein (Lauzé
et al., 1995). In the cdc37-1 assays, where kinase activity
was significantly reduced, few hyperphosphorylated spe-
cies were produced and ProA-Mps1p migrated primarily
as a single band (Fig. 8 a, arrow). Although these experi-
ments were performed with epitope-tagged Mps1p, the
tagged proteins are functional and for kinase activity ex-
periments were expressed at endogenous levels, so we be-
lieve that these data reflect the behavior of wild-type
Mps1p. Our observations indicate that loss of Mps1p pro-
tein kinase activity contributes to the cdc37-1 mutant phe-
notype described here and suggest that this effect occurs
not through destabilization of Mps1p but by some other
type of posttranslational regulation.
Discussion
We describe here the identification of CDC37 as an allele-
specific multicopy suppressor of a temperature-sensitive
mutation in MPS1. These two genes also show allele-spe-
cific synthetic lethal interactions. CDC37 was originally
identified by Reed (1980a) as a gene required for the exe-
cution of Start. Examination of the SPBs in cdc37-1 cells
incubated at the nonpermissive temperature reveals an
unusual phenotype: SPB duplication has begun in these ar-
rested cells, but they are still mating pheromone respon-
Figure 7. Steady-state levels and half-life of Mps1 fusion proteins
are unaffected by mutation of CDC37. (a) Steady-state levels of
ProA-Mps1p were assessed in wild-type and cdc37-1 strains.
AS231-2d and AS231-2b (Table I), which carry the integrated
protein A–tagged allele of MPS1, were grown at 258C and then
shifted to 388C for 4 and 8 h. ProA-Mps1p was detected in whole
cell lysates using rabbit IgG as primary antibody. Protein levels
were unaffected even after an 8-h incubation at the nonpermis-
sive temperature. (b) The half-life of a pool of galactose-induced
myc-Mps1p was monitored in wild-type (AS230-7a) and cdc37-1
(AS230-7b) strains upon shift to the nonpermissive temperature.
Expression of the fusion protein was induced with galactose at
258C for 6 h; glucose was then added to the culture to repress the
promoter, and the culture was divided. Cells were incubated at 25
or 388C and sampled every 15 min for 1 h. Lysates were made and
myc-Mps1p detected with 9E10 antibody. No reduction in half-
life is seen at the nonpermissive temperature.
Figure 8. The cdc37-1 mutation reduces ProA-Mps1p kinase ac-
tivity. (a) Wild-type (AS231-2d, wt) and mutant (AS231-2b,
cdc37-1; Table I) strains carrying the protein A–tagged allele of
MPS1 were cultured at 258C, and some cells were shifted to 388C
for 1 h. Cells were lysed, ProA-Mps1p was immunoprecipitated
and assayed for autophosphorylation activity, and kinase activity
was normalized for the amount of ProA-Mps1p present in the ly-
sates (Materials and Methods). Autophosphorylation signal is re-
duced in the cdc37-1 strain even at 258C (two- to threefold lower
activity than wild-type), and drops further after incubation at the
nonpermissive temperature (four- to fivefold less than wild-type;
1 h 388C). Normalized activity values from four independent as-
says were averaged for each strain and temperature. (b) Cell cy-
cle distribution in each culture was monitored by flow cytometry.
The reduction in kinase activity seen after 1 h at 388C occurs be-
fore any G1 bias has appeared in the cdc37-1 culture. The x-axis
is the relative DNA content determined by propidium iodide flu-
orescence, and the y-axis is the relative number of cells (Materi-
als and Methods). Each sample represents 10,000 cells.Schutz et al. Yeast CDC37 Gene 979
sive. Thus, the cdc37-1 arrest point represents a novel
Start arrest, where events at Start have become uncoordi-
nated and the side-by-side SPB structure that is produced
is not completely normal. The outer plaque on one SPB is
reduced or absent, and the mps2-1 cdc37-1 synthetic phe-
notype suggests that this defect belongs to the newly
formed SPB. Mutation of CDC37 reduces the kinase activ-
ity of a ProA-Mps1p fusion protein, indicating that low
Mps1p activity may cause this SPB duplication defect.
Cell Cycle and SPB Phenotypes of cdc37-1 Cells
At the nonpermissive temperature, the cdc37-1 mutation
confers a unique SPB phenotype. At cdc37-1 arrest, the
duplication event has already begun. Two central plaques
joined by a full bridge are seen in these cells, and microtu-
bules emanate from the nuclear surfaces of both SPBs.
(This phenotype has also been observed by Johnson [1991].)
However, the cells harboring this side-by-side SPB struc-
ture behave as if they are blocked at Start in that they are
responsive to mating pheromone. Thus, this phenotype
defines a novel Start arrest. The point of Start has been
previously defined by the presence of a single, satellite-
bearing SPB (Byers and Goetsch, 1974, 1975). In this case,
that morphological marker is not present. However, the
reciprocal shift experiment examining cdc and a-factor ar-
rest demonstrates that the cells are functionally arrested at
Start. One aspect of the cell cycle, SPB duplication, has
been uncoupled from other indicators of cell cycle pro-
gression through G1.
Although SPB duplication has begun in these cells, it
has not been successfully completed. The central plaques
appear normal, and both SPBs nucleate microtubules on
their nuclear surfaces; however, one structural aspect is
obviously abnormal. The outer plaque on one SPB is miss-
ing or reduced. Several explanations could account for this
defect. The cdc37-1 mutation might cause a faulty duplica-
tion event to take place, where an aberrant structure is
formed when outer plaque assembly is disrupted and pro-
ceeds only partially or not at all. Alternatively, the outer
plaque may have been assembled properly but is unstable
in some way, and part or all of it is lost during sustained in-
cubation at the nonpermissive temperature. Another pos-
sibility is that the cdc37-1 mutation blocks the SPB dupli-
cation cycle at an intermediate step in assembly—a step
that occurs normally, but has not yet been captured in
asynchronous wild-type populations. Satellite-bearing SPBs
are seen in cycling populations of cells, but the transition
to duplicated side-by-side SPBs is thought to occur rapidly
because no structure corresponding to a transition state
has been reported (Byers and Goetsch, 1975). In other cdc
mutants such as cdc4 and cdc34, which arrest in G1 with
two side-by-side SPBs, both SPBs bear outer plaques on
their cytoplasmic faces (Byers and Goetsch, 1974; Goebl
et al., 1988). It is unclear how the SPBs seen at cdc37-1 ar-
rest could mediate the low level of successful karyogamy
reported by Reed (1980a), since that event begins with fu-
sion of unduplicated SPBs beginning at their satellites
(Byers and Goetsch, 1975). One possibility is that this in-
complete structure can behave as an unduplicated SPB, al-
though not efficiently. Alternatively, our observation that
cdc37-1 cells require a long incubation at the nonpermis-
sive temperature to reach uniform arrest might explain the
mating competence. The reported mating assays involved
a relatively short preincubation at high temperature, and
observed mating events might have been contributed by a
small number of cells that had not yet reached the arrest.
The fact that only one SPB is affected by the cdc37-1
mutation could result from the presumed conservative na-
ture of the SPB duplication event (Winey et al., 1991;
Vallen et al., 1992). Phenotypic analysis of an mps2-1
cdc37-1 double mutant strain allowed us to address this
question. The mps2-1 mutation makes the SPBs nonequiv-
alent, with the apparently preexisting SPB marked by its
proper location in the nuclear envelope (Winey et al.,
1991). Using this marker, we conclude that the existing
SPB is unaffected by the cdc37-1 mutation, because the
SPB found in the nuclear envelope appears completely
normal. The nascent SPB, however, is affected. The defec-
tive SPB morphology seen in an mps2-1 single mutant is
not observed. Instead, a clump of electron-dense material
on the cytoplasmic face of the half-bridge is seen in many
cells. We suggest that this material may be the remnants of
the new SPB. Given the mps2 phenotype, we would expect
the new SPB to lie outside the plane of the nuclear enve-
lope and to bear no microtubules on its “nuclear” face.
The structure might also lack an outer plaque because of
the cdc37-1 mutation. We might therefore expect to see a
clump of electron-dense central plaque material that is dis-
continuous with the nuclear envelope, consistent with the
observed morphology.
Although MPS1 and CDC37 interact genetically, their
mutant phenotypes differ with respect to cell cycle behav-
ior and SPB morphology. Epistasis analysis shows that
mps1 cdc37 double mutant strains exhibit G1 arrest but
display a typical mps1 SPB structure, with a single en-
larged SPB and half-bridge. Presence of the mps1 pheno-
type in the double mutant strain indicates that the mps1
mutation blocks SPB duplication earlier in the pathway
than the cdc37-1 mutation (Fig. 9). This precludes expres-
sion of the cdc37 phenotype, which requires some later
step or steps in duplication to develop. Since mps1 cdc37
strains arrest efficiently in G1, the cdc37-terminal SPB
phenotype need not be reached for G1 arrest to occur.
The Molecular Role of CDC37 in the Cell Cycle
CDC37 shows interactions not only with MPS1, but with
several other protein kinase genes. CDC37 has been linked
with genes encoding the cyclin-dependent kinase Cdc28p
(Gerber et al., 1995; Reed et al., 1985), Kin28p (Valay et al.,
1995), casein kinase II (McCann, R., and C. Glover, per-
sonal communication), and mammalian pp60v-src heterolo-
gously expressed in yeast (Boschelli et al., 1993; Dey et al.,
1996b). The complicity of CDC37 with this collection of
protein kinases has led to the idea that the gene may play a
somewhat general role in kinase function, perhaps in pro-
tein folding or complex assembly. Circumstantial evidence
supports this idea; CDC37 has been implicated in several
situations that also involve the action of molecular chaper-
ones. One example derives from the expression of pp60v-src
in yeast. Activity of this kinase requires two yeast chaper-
one genes: HSP90 (Xu and Lindquist, 1993; Nathan and
Lindquist, 1995) and YDJ1, a DnaJ homologue (Bohen etThe Journal of Cell Biology, Volume 136, 1997 980
al., 1995; Caplan et al., 1995; Kimura et al., 1995; Dey et al.,
1996a); it also requires CDC37 function (Boschelli et al.,
1993; Dey et al., 1996b). Interestingly, we too have found a
connection with YDJ1. An allele of this gene was recov-
ered as a synthetic lethal with mps1-1 (Bachant, J., and M.
Winey, unpublished observations). A similar link to chap-
erones is found in Drosophila, where mutation of the fly
Cdc37 homologue enhances the sevenless receptor tyro-
sine kinase mutant phenotype, and mutation of Hsp83 (a
member of the Hsp90 family) has the same effect (Cut-
forth and Rubin, 1994).
A chaperone function for mammalian Cdc37 has re-
cently been demonstrated directly. Stepanova et al. (1996)
have found that Cdc37 is the long-known but previously
unidentified p50 subunit of the Hsp90 molecular chaper-
one complex, and they suggest that this protein targets
Hsp90 to the Cdk4 kinase. Cdc37/Hsp90 binds the fraction
of Cdk4 that is not associated with cyclins, and pharmaco-
logical disruption of Cdc37/Hsp90 function in cultured
cells decreases Cdk4 half-life. This effect on kinase sta-
bility appears to extend to the oncoprotein kinases Raf-1
and pp60v-src as well. Both associate with the p50Cdc37/
Hsp90 complex and are destabilized when that complex is
inactivated (Whitesel et al., 1994; Nathan and Lindquist,
1995; Schulte et al., 1995).
Does this stability mechanism hold true in yeast? The
relationship between chaperone function and kinase activ-
ity has been previously examined for both Cdc28p and
pp60v-src. Although kinase stability is affected in both in-
stances, destabilization may not be the primary reason for
loss of kinase activity in the cell. Cdc28p levels do drop
somewhat in cdc37-1 cells, but while reduction in kinase
activity is temperature dependent, the reduced protein
level is not. At the nonpermissive temperature, Cdc28p is
still present in excess over the Cln2p cyclin but does not
bind normally to it, suggesting a role for Cdc37p in assem-
bly of active kinase complexes (Gerber et al., 1995). In the
case of pp60v-src, cdc37 and hsp90 mutations can influence
both accumulation and activity of the kinase, but these ef-
fects are distinct and separable (Nathan and Lindquist,
1995; Dey et al., 1996b). We now report that Mps1p kinase
activity, but not stability, depends upon CDC37 function.
Although the epitope tags we used to monitor Mps1p
could potentially affect stability, these proteins were func-
tional and behaved similarly with two different tags, sug-
gesting that their properties resemble those of the wild-
type protein. The difference observed in CDC37 and/or
HSP90 function between yeast and mammals could be ex-
plained in several ways. It may be that the mechanisms of
action are different in the two organisms, but it is impor-
tant to bear in mind that unlike Cdk4, direct physical inter-
action between Cdc28p and Cdc37p has not been re-
ported, and we have not detected binding of Cdc37p to
Mps1p (Schutz, A., and M. Winey, unpublished observa-
tion). Cdc37p might actually do its work one or more steps
away from Mps1p in the SPB duplication pathway, per-
haps by stabilizing an upstream kinase, and thus we would
not observe a requirement for Mps1p stability. This rela-
tionship could be complex; even if Cdc37p does act di-
rectly on Mps1p, it may also have indirect effects on Mps1p
activity through modulation of other G1 kinases, possibly
including Cdc28p. Experimental evaluation of the relative
contributions of direct and indirect effects may be difficult.
Multiple requirements for CDC37 function in the cell
may be responsible for the unusual phenotype observed in
cdc37-1 mutant strains, which includes defects both in co-
ordination of events at Start and in SPB duplication. We
and others have shown that the cdc37-1 mutation reduces
the in vitro kinase activity of both Cdc28p and Mps1p, en-
zymes that are required for these events and act very close
together in G1 (Fig. 9). A reduced level of phosphoryla-
tion by Cdc28p at cdc37-1 arrest, possibly combined with
effects on other G1 kinases such as casein kinase II, may
cause confusion about the G1 status of a cdc37-1 cell. In
this situation, some aspects of the cell cycle would be
blocked at Start, but residual Cdc28p activity might be suf-
ficient to trigger the SPB duplication pathway. Why then
would SPB duplication not proceed to completion? The
structural and genetic evidence presented here suggests
that CDC37 functions downstream of MPS1, since a
cdc37-1 mutant proceeds considerably farther in SPB du-
plication than an mps1-1 mutant does before the process
stalls, but the requirement of CDC37 for Mps1p kinase ac-
tivity contradicts this interpretation. We propose that the
cdc37-1 SPB phenotype arises from significant but not
complete loss of Mps1p kinase activity. Phenotypic analy-
sis of mps1 alleles indicates that this kinase is required not
only to begin SPB duplication, but also to carry it to com-
pletion (Schutz, A., and M. Winey, unpublished observa-
tion). At the nonpermissive temperature, a cdc37-1 mu-
Figure 9. Proposed SPB duplication pathway,
showing the requirement for CDC37 function in
timing and execution of this event (adapted from
Winey and Byers, 1993). CDC28 and MPS1 act
at nearly the same time in the early stages of du-
plication. The cdc37-1 mutant phenotype may re-
sult from effects on both kinases, and CDC37
might also affect CDC28 function later in the cell
cycle. The “1” signs indicate both genetic and
biochemical links but do not necessarily imply
physical interaction between the gene products.
Note that the requirement for CDC37 function
in SPB duplication occurs later than the require-
ment for CDC37 in the execution of Start. The aberrant SPB structures in mps2 and cdc37 strains are shown branching off from the
pathway at the same point. Because mps2 cdc37 double mutant strains display a synthetic phenotype rather than a clear epistatic rela-
tionship, the execution points of these two genes cannot be ordered relative to one another.Schutz et al. Yeast CDC37 Gene 981
tant strain may retain sufficient kinase activity to initiate
duplication, but too little to actually finish the process.
This study addresses G1 functions of CDC37, but this
gene may also be important in other stages of the cell cy-
cle. The alleles discussed here were specifically selected
for their behavior at Start (Reed 1980a, b) and may not ad-
dress all the requirements for CDC37. Several of the pro-
tein kinases intimate with CDC37 perform functions later
in the cell cycle, raising the possibility that CDC37 could
also be important after G1. Mps1p participates in a spindle
assembly checkpoint in G2/M (Weiss and Winey, 1996),
and casein kinase II is also required around this time
(Hanna et al., 1995). Similarly, Cdc28p is required to pro-
mote cell cycle progression not only at Start, but also in
S phase and in G2/M (for review see Nasmyth, 1993; Fig. 9).
Gerber et al. (1995) report biochemical evidence for a
CDC37 requirement in G2/M: cdc37-1 mutant strains also
exhibit a defect in binding and activation of Cdc28p by the
mitotic cyclin Clb2p. The recent isolation of CDC37 alleles
that affect pp60v-src activity and cause a G2/M cell cycle ar-
rest provides genetic evidence to bolster this idea (Dey et
al., 1996b). A variety of alleles of this gene may be needed
to explore and understand the functions of CDC37 in G1
and throughout the cell cycle.
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